All-American Allergy Alternatives, LLC announces availability of prescription Allergy Toothpaste

Allergy toothpaste enables the regular administration of allergy immunotherapy while a user brushes their teeth. Allergy toothpaste is custom-formulated for each patient by prescription and is available in mint and berry flavors.
 
Allergy toothpaste pictured with allergy drops.  © 2016.
Allergy toothpaste pictured with allergy drops. © 2016.
APPLETON, Wis. - Oct. 3, 2016 - PRLog -- All-American Allergy Alternatives, LLC, a specialty compounding pharmacy focused on the treatment of allergic diseases and a leading provider of allergy drops prescription services, announces the availability of allergy toothpaste, also known as Oral Mucosal Immunotherapy (OMIT).

James Luzader, Director of Sales, said, "The pharmacy is pleased to offer allergy toothpaste based on the work of Dr. William Reisacher and the team at Allovate Therapeutics. It expands the options our prescribers have to treat patients who may not be able to comply with the administration of allergy injections.

"All-American Allergy Alternatives, LLC's pharmacy serves the needs of many types of prescribers, including otolaryngologists, pediatricians and integrative medicine specialists who treat rhinitis, sinusitis and conditions such as autism, Lyme and other chronic diseases. Reducing the allergic load by developing tolerance to inhalant allergens can be very beneficial to these patients and prevent the onset of complications such as asthma, anaphylaxis, atopic dermatitis or the side effects of long-term medication use.

"Dr. Reisacher's research(1) has shown that allergy toothpaste provides similar immunologic benefits as allergy shots or drops, making allergy toothpaste a safe and effective option to treat the underlying cause of allergic disease."

About Allergy Toothpaste

According to Allovate Therapeutics, respiratory allergies affect at least 60 million people in the United States, resulting in over 11 million doctor visits annually. Symptomatic treatment, at a global cost of over $25 billion yearly, keeps symptoms at bay temporarily but does not offer a long-term solution.

Allergen-specific immunotherapy is the only treatment method that targets the root cause of the disease. Immunotherapy has traditionally been administered by injecting allergens into the skin (subcutaneous immunotherapy) or placing them under the tongue (sublingual immunotherapy).

Oral mucosal immunotherapy (OMIT) uses a patented, specially formulated toothpaste to incorporate and stabilize allergenic proteins that are administered while a user brushes their teeth, delivering key agents to the areas of the oral cavity with the highest density of the immune cells responsible for initiating desensitization. OMIT simplifies long-term daily adherence to immunotherapy for patients, offering a potential solution to the "crisis of compliance" in allergy immunotherapy.

About All-American Allergy Alternatives, LLC

The company was founded in 2007 by Otolaryngologist Todd Meyer, DO, FAAOA, FAOCO, to provide immunotherapy prescription services to meet the needs of practitioners and their allergic patients. Today, the company operates its compounding pharmacy in Appleton, WI servicing prescribers in many states across the US. To become a prescriber, or to locate one in your community, please visit: http://www.allamericanallergy.com for more information.

Reference:

(1). Oral mucosal immunotherapy for allergic rhinitis: a pilot study. Reisacher W, et al. Allergy Rhinol 2016; 7(1): e21-28

Media Contact
All-American Allergy Alternatives, LLC
James Luzader
877-667-4689, Ext 7
questions@allamericanallergy.com

Photo:
https://www.prlog.org/12591419/1
End



Like PRLog?
9K2K1K
Click to Share